{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:26:32Z","timestamp":1791354392606,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21390"],"award-info":[{"award-number":["21390"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2018"],"award-info":[{"award-number":["IG 2018"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejca.2021.12.023","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T23:14:07Z","timestamp":1642029247000},"page":"44-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment"],"prefix":"10.1016","volume":"163","author":[{"given":"Marika","family":"Sculco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1103-6223","authenticated-orcid":false,"given":"Marta","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4944-0990","authenticated-orcid":false,"given":"Anna","family":"Aspesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela G.","family":"Clavenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Casalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-309X","authenticated-orcid":false,"given":"Alessandra","family":"Allione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Libener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-1829","authenticated-orcid":false,"given":"Ottavio","family":"Rena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Baietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-6247","authenticated-orcid":false,"given":"Sara","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-6726","authenticated-orcid":false,"given":"Daniela","family":"Giachino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio V.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-1342","authenticated-orcid":false,"given":"Dario","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.12.023_bib1","first-page":"9","article-title":"Outdoor air pollution","volume":"109","year":"2016","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.ejca.2021.12.023_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.critrevonc.2016.05.004","article-title":"The third Italian consensus conference for malignant pleural mesothelioma: state of the art and recommendations","volume":"104","author":"Novello","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2021.12.023_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1289\/ehp.01109915","article-title":"Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy","volume":"109","author":"Magnani","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ejca.2021.12.023_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/oemed-2015-102803","article-title":"Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment","volume":"73","author":"Ferrante","year":"2016","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ejca.2021.12.023_bib5","first-page":"502","article-title":"FDA approves nivolumab plus ipilimumab for previously untreated unresectable malignant pleural mesothelioma","volume":"34","author":"Wright","year":"2020","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejca.2021.12.023_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2017.06.028","article-title":"Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma","volume":"405","author":"Betti","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2021.12.023_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2021.12.023_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2021.12.023_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.22670","article-title":"Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes","volume":"57","author":"Betti","year":"2018","journal-title":"Gene Chromosome Cancer"},{"key":"10.1016\/j.ejca.2021.12.023_bib10","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.023_bib11","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2018.79.0352","article-title":"A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations","volume":"36","author":"Pastorino","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.023_bib12","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2021.12.023_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-019-0087-6","article-title":"High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer","volume":"4","author":"Bertelsen","year":"2019","journal-title":"Npj Genomic Med"},{"key":"10.1016\/j.ejca.2021.12.023_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jtho.2019.12.111","article-title":"Novel germline mutations in DNA damage repair in patients with malignant pleural mesotheliomas","volume":"15","author":"Guo","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2021.12.023_bib15","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddab138","article-title":"Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors","volume":"30","author":"Cheung","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2021.12.023_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41588-021-00949-1","article-title":"The context-specific role of germline pathogenicity in tumorigenesis","volume":"53","author":"Srinivasan","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2021.12.023_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22218","article-title":"Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area","volume":"54","author":"Betti","year":"2015","journal-title":"Gene Chromosome Cancer"},{"key":"10.1016\/j.ejca.2021.12.023_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2016.05.011","article-title":"CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma","volume":"378","author":"Betti","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2021.12.023_bib19","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1073\/pnas.2019652117","article-title":"Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma","volume":"117","author":"Bononi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2021.12.023_bib20","article-title":"Changes in global gene expression associated with 3D structure of tumors: an ex\u00a0vivo matrix-free mesothelioma spheroid model","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2021.12.023_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2 is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2021.12.023_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2021.12.023_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1751-1097.2011.00995.x","article-title":"\u03b3h2Ax: biomarker of damage or functional participant in DNA repair \u201call that glitters is not gold!\u201d","volume":"87","author":"Cleaver","year":"2011","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ejca.2021.12.023_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124327","article-title":"Inherited genetic mutations and polymorphisms in malignant mesothelioma: a comprehensive review","volume":"21","author":"Panou","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2021.12.023_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ejca.2021.12.023_bib26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/em.22397","article-title":"Roles of Chk2\/CHEK2 in guarding against environmentally induced DNA damage and replication-stress","volume":"61","author":"Mustofa","year":"2020","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.ejca.2021.12.023_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102091","article-title":"BAP1: not just a BRCA1-associated protein","volume":"90","author":"Louie","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2021.12.023_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145243","article-title":"Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib","volume":"769","author":"Zhang","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.ejca.2021.12.023_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00921-w","article-title":"Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes","volume":"8","author":"Riaz","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ejca.2021.12.023_bib30","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the north western cape province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.ejca.2021.12.023_bib31","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.21037\/tlcr.2020.02.01","article-title":"How asbestos and other fibers cause mesothelioma","volume":"9","author":"Gaudino","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejca.2021.12.023_bib32","article-title":"Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer","author":"George","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2021.12.023_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","article-title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","volume":"18","author":"Swisher","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2021.12.023_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2213-2600(20)30390-8","article-title":"Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial","volume":"9","author":"Fennell","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ejca.2021.12.023_bib35","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.cllc.2020.07.014","volume":"22","author":"Passiglia","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2021.12.023_bib36","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.celrep.2020.01.052","article-title":"Cooperation of the ATM and Fanconi anemia\/BRCA pathways in double-strand break end resection","volume":"30","author":"Cai","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.ejca.2021.12.023_bib37","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1200\/JCO.2020.38.15_suppl.9058","article-title":"Safety and efficacy of tazemetostat, an enhancer of zeste-homolog 2 inhibitor, in patients with relapsed or refractory malignant mesothelioma","volume":"38","author":"Zauderer","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2021.12.023_bib38","doi-asserted-by":"crossref","first-page":"678447","DOI":"10.3389\/fonc.2021.678447","article-title":"CDKN2A determines mesothelioma cell fate to EZH2 inhibition","volume":"1","author":"Pinton","year":"2021","journal-title":"Front Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921013046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921013046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:34:46Z","timestamp":1760733286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921013046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":38,"alternative-id":["S0959804921013046"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.12.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}